Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in poor-risk advanced head and neck cancer
NCT00293579Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Feb 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in head and neck squamous cell carcinoma (HNSCC), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Feb 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00293579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293579.